Table of Contents Executive Summary 1 Industry Overview of Performance Enhancing Drugs 1.1 Definition of Performance Enhancing Drugs 1.2 Performance Enhancing Drugs Segment by Type 1.2.1 Global Performance Enhancing Drugs Production Growth Rate Comparison by Type (2014-2025) 1.2.2 Ergogenic Aids 1.2.3 Nootropic 1.3 Performance Enhancing Drugs Segment by Applications 1.3.1 Global Performance Enhancing Drugs Consumption Comparison by Applications (2014-2025) 1.3.2 Athletes 1.3.3 Body Builders 1.3.4 Students 1.3.5 Militaries 1.4 Global Performance Enhancing Drugs Overall Market 1.4.1 Global Performance Enhancing Drugs Revenue (2014-2025) 1.4.2 Global Performance Enhancing Drugs Production (2014-2025) 1.4.3 North America Performance Enhancing Drugs Status and Prospect (2014-2025) 1.4.4 Europe Performance Enhancing Drugs Status and Prospect (2014-2025) 1.4.5 China Performance Enhancing Drugs Status and Prospect (2014-2025) 1.4.6 Japan Performance Enhancing Drugs Status and Prospect (2014-2025) 1.4.7 Southeast Asia Performance Enhancing Drugs Status and Prospect (2014-2025) 1.4.8 India Performance Enhancing Drugs Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Performance Enhancing Drugs 2.3 Manufacturing Process Analysis of Performance Enhancing Drugs 2.4 Industry Chain Structure of Performance Enhancing Drugs 3 Development and Manufacturing Plants Analysis of Performance Enhancing Drugs 3.1 Capacity and Commercial Production Date 3.2 Global Performance Enhancing Drugs Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Performance Enhancing Drugs 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Performance Enhancing Drugs Production and Capacity Analysis 4.2 Performance Enhancing Drugs Revenue Analysis 4.3 Performance Enhancing Drugs Price Analysis 4.4 Market Concentration Degree 5 Performance Enhancing Drugs Regional Market Analysis 5.1 Performance Enhancing Drugs Production by Regions 5.1.1 Global Performance Enhancing Drugs Production by Regions 5.1.2 Global Performance Enhancing Drugs Revenue by Regions 5.2 Performance Enhancing Drugs Consumption by Regions 5.3 North America Performance Enhancing Drugs Market Analysis 5.3.1 North America Performance Enhancing Drugs Production 5.3.2 North America Performance Enhancing Drugs Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Performance Enhancing Drugs Import and Export 5.4 Europe Performance Enhancing Drugs Market Analysis 5.4.1 Europe Performance Enhancing Drugs Production 5.4.2 Europe Performance Enhancing Drugs Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Performance Enhancing Drugs Import and Export 5.5 China Performance Enhancing Drugs Market Analysis 5.5.1 China Performance Enhancing Drugs Production 5.5.2 China Performance Enhancing Drugs Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Performance Enhancing Drugs Import and Export 5.6 Japan Performance Enhancing Drugs Market Analysis 5.6.1 Japan Performance Enhancing Drugs Production 5.6.2 Japan Performance Enhancing Drugs Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Performance Enhancing Drugs Import and Export 5.7 Southeast Asia Performance Enhancing Drugs Market Analysis 5.7.1 Southeast Asia Performance Enhancing Drugs Production 5.7.2 Southeast Asia Performance Enhancing Drugs Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Performance Enhancing Drugs Import and Export 5.8 India Performance Enhancing Drugs Market Analysis 5.8.1 India Performance Enhancing Drugs Production 5.8.2 India Performance Enhancing Drugs Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Performance Enhancing Drugs Import and Export 6 Performance Enhancing Drugs Segment Market Analysis (by Type) 6.1 Global Performance Enhancing Drugs Production by Type 6.2 Global Performance Enhancing Drugs Revenue by Type 6.3 Performance Enhancing Drugs Price by Type 7 Performance Enhancing Drugs Segment Market Analysis (by Application) 7.1 Global Performance Enhancing Drugs Consumption by Application 7.2 Global Performance Enhancing Drugs Consumption Market Share by Application (2014-2019) 8 Performance Enhancing Drugs Major Manufacturers Analysis 8.1 Taj Pharmaceuticals 8.1.1 Taj Pharmaceuticals Performance Enhancing Drugs Production Sites and Area Served 8.1.2 Taj Pharmaceuticals Product Introduction, Application and Specification 8.1.3 Taj Pharmaceuticals Performance Enhancing Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 Balkan Pharmaceuticals 8.2.1 Balkan Pharmaceuticals Performance Enhancing Drugs Production Sites and Area Served 8.2.2 Balkan Pharmaceuticals Product Introduction, Application and Specification 8.2.3 Balkan Pharmaceuticals Performance Enhancing Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 Bayer 8.3.1 Bayer Performance Enhancing Drugs Production Sites and Area Served 8.3.2 Bayer Product Introduction, Application and Specification 8.3.3 Bayer Performance Enhancing Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 AstraZeneca 8.4.1 AstraZeneca Performance Enhancing Drugs Production Sites and Area Served 8.4.2 AstraZeneca Product Introduction, Application and Specification 8.4.3 AstraZeneca Performance Enhancing Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 Novo Nordisk 8.5.1 Novo Nordisk Performance Enhancing Drugs Production Sites and Area Served 8.5.2 Novo Nordisk Product Introduction, Application and Specification 8.5.3 Novo Nordisk Performance Enhancing Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 8.6 BrainAlert 8.6.1 BrainAlert Performance Enhancing Drugs Production Sites and Area Served 8.6.2 BrainAlert Product Introduction, Application and Specification 8.6.3 BrainAlert Performance Enhancing Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.6.4 Main Business and Markets Served 8.7 Douglas Laboratories 8.7.1 Douglas Laboratories Performance Enhancing Drugs Production Sites and Area Served 8.7.2 Douglas Laboratories Product Introduction, Application and Specification 8.7.3 Douglas Laboratories Performance Enhancing Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.7.4 Main Business and Markets Served 8.8 Onnit Labs 8.8.1 Onnit Labs Performance Enhancing Drugs Production Sites and Area Served 8.8.2 Onnit Labs Product Introduction, Application and Specification 8.8.3 Onnit Labs Performance Enhancing Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.8.4 Main Business and Markets Served 8.9 Eli Lilly And Company 8.9.1 Eli Lilly And Company Performance Enhancing Drugs Production Sites and Area Served 8.9.2 Eli Lilly And Company Product Introduction, Application and Specification 8.9.3 Eli Lilly And Company Performance Enhancing Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.9.4 Main Business and Markets Served 9 Development Trend of Analysis of Performance Enhancing Drugs Market 9.1 Global Performance Enhancing Drugs Market Trend Analysis 9.1.1 Global Performance Enhancing Drugs Market Size (Volume and Value) Forecast 2019-2025 9.2 Performance Enhancing Drugs Regional Market Trend 9.2.1 North America Performance Enhancing Drugs Forecast 2019-2025 9.2.2 Europe Performance Enhancing Drugs Forecast 2019-2025 9.2.3 China Performance Enhancing Drugs Forecast 2019-2025 9.2.4 Japan Performance Enhancing Drugs Forecast 2019-2025 9.2.5 Southeast Asia Performance Enhancing Drugs Forecast 2019-2025 9.2.6 India Performance Enhancing Drugs Forecast 2019-2025 9.3 Performance Enhancing Drugs Market Trend (Product Type) 9.4 Performance Enhancing Drugs Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Performance Enhancing Drugs Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Performance Enhancing Drugs Table Global Performance Enhancing Drugs Production (K Units) Growth Rate Comparison by Types (2014-2025) Figure Global Performance Enhancing Drugs Production Market Share by Types in 2018 Figure Ergogenic Aids Product Picture Figure Nootropic Product Picture Table Global Performance Enhancing Drugs Consumption (K Units) Comparison by Applications (2014-2025) Figure Global Performance Enhancing Drugs Consumption Market Share by Applications in 2018 Figure Athletes Figure Body Builders Figure Students Figure Militaries Figure Global Performance Enhancing Drugs Revenue (Million USD) (2014-2025) Figure Global Performance Enhancing Drugs Production (K Units) (2014-2025) Figure North America Performance Enhancing Drugs Market Size (Million USD) (2014-2025) Figure Europe Performance Enhancing Drugs Market Size (Million USD) (2014-2025) Figure China Performance Enhancing Drugs Market Size (Million USD) (2014-2025) Figure Japan Performance Enhancing Drugs Market Size (Million USD) (2014-2025) Figure Southeast Asia Performance Enhancing Drugs Market Size (Million USD) (2014-2025) Figure India Performance Enhancing Drugs Market Size (Million USD) (2014-2025) Table Performance Enhancing Drugs Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Performance Enhancing Drugs in 2018 Figure Manufacturing Process Analysis of Performance Enhancing Drugs Figure Industry Chain Structure of Performance Enhancing Drugs Table Capacity and Commercial Production Date of Key Manufacturers Table Global Performance Enhancing Drugs Manufacturing Plants Distribution Table Performance Enhancing Drugs Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Performance Enhancing Drugs Capacity (K Units) of Major Manufacturers (2014-2019) Table Performance Enhancing Drugs Production (K Units) of Major Manufacturers (2014-2019) Table Performance Enhancing Drugs Production Market Share of Major Manufacturers (2014-2019) Figure Performance Enhancing Drugs Production Share by Manufacturers in 2018 Table Performance Enhancing Drugs Revenue (Million US$) of Major Manufacturers (2014-2019) Table Performance Enhancing Drugs Revenue Market Share of Major Manufacturers (2014-2019) Figure Performance Enhancing Drugs Revenue Share by Manufacturers in 2018 Table Performance Enhancing Drugs Average Price (USD/Unit) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Performance Enhancing Drugs Production by Regions 2014-2019 (K Units) Table Global Performance Enhancing Drugs Production Market Share by Regions 2014-2019 Figure Global Performance Enhancing Drugs Production Market Share by Regions in 2018 Table Global Performance Enhancing Drugs Revenue by Regions 2014-2019 (Million USD) Table Global Performance Enhancing Drugs Revenue Market Share by Regions 2014-2019 Figure Global Performance Enhancing Drugs Revenue Market Share by Regions in 2018 Table Global Performance Enhancing Drugs Consumption by Regions 2014-2019 (K Units) Table Global Performance Enhancing Drugs Consumption Market Share by Regions 2014-2019 Figure North America Performance Enhancing Drugs Production Growth Rate 2014-2019 (K Units) Figure North America Performance Enhancing Drugs Revenue Growth Rate 2014-2019 (Million USD) Table North America Performance Enhancing Drugs Production, Consumption Import and Export (K Units) Figure Europe Performance Enhancing Drugs Production Growth Rate 2014-2019 (K Units) Figure Europe Performance Enhancing Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Europe Performance Enhancing Drugs Production, Consumption Import and Export (K Units) Figure China Performance Enhancing Drugs Production Growth Rate 2014-2019 (K Units) Figure China Performance Enhancing Drugs Revenue Growth Rate 2014-2019 (Million USD) Table China Performance Enhancing Drugs Production, Consumption Import and Export (K Units) Figure Japan Performance Enhancing Drugs Production Growth Rate 2014-2019 (K Units) Figure Japan Performance Enhancing Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Japan Performance Enhancing Drugs Production, Consumption Import and Export (K Units) Figure Southeast Asia Performance Enhancing Drugs Production Growth Rate 2014-2019 (K Units) Figure Southeast Asia Performance Enhancing Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Performance Enhancing Drugs Production, Consumption Import and Export (K Units) Figure India Performance Enhancing Drugs Production Growth Rate 2014-2019 (K Units) Figure India Performance Enhancing Drugs Revenue Growth Rate 2014-2019 (Million USD) Table India Performance Enhancing Drugs Production, Consumption Import and Export (K Units) Figure Global Consumption Performance Enhancing Drugs Market Share by Application (2014-2019) Figure Global Value (Consumption) Performance Enhancing Drugs Market Share by Application (2014-2019) Table Taj Pharmaceuticals Performance Enhancing Drugs Production Sites and Area Served Table Taj Pharmaceuticals Performance Enhancing Drugs Product Introduction, Application and Specification Table Taj Pharmaceuticals Performance Enhancing Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Taj Pharmaceuticals Performance Enhancing Drugs Production Growth Rate (2014-2019) Table Taj Pharmaceuticals Performance Enhancing Drugs Production Market Share (2014-2019) Figure Taj Pharmaceuticals Performance Enhancing Drugs Revenue Market Share (2014-2019) Table Taj Pharmaceuticals Performance Enhancing Drugs Main Business and Markets Served Table Balkan Pharmaceuticals Performance Enhancing Drugs Production Sites and Area Served Table Balkan Pharmaceuticals Performance Enhancing Drugs Product Introduction, Application and Specification Table Balkan Pharmaceuticals Performance Enhancing Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Balkan Pharmaceuticals Performance Enhancing Drugs Production Growth Rate (2014-2019) Table Balkan Pharmaceuticals Performance Enhancing Drugs Production Market Share (2014-2019) Figure Balkan Pharmaceuticals Performance Enhancing Drugs Revenue Market Share (2014-2019) Table Balkan Pharmaceuticals Performance Enhancing Drugs Main Business and Markets Served Table Bayer Performance Enhancing Drugs Production Sites and Area Served Table Bayer Performance Enhancing Drugs Product Introduction, Application and Specification Table Bayer Performance Enhancing Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Bayer Performance Enhancing Drugs Production Growth Rate (2014-2019) Table Bayer Performance Enhancing Drugs Production Market Share (2014-2019) Figure Bayer Performance Enhancing Drugs Revenue Market Share (2014-2019) Table Bayer Performance Enhancing Drugs Main Business and Markets Served Table AstraZeneca Performance Enhancing Drugs Production Sites and Area Served Table AstraZeneca Performance Enhancing Drugs Product Introduction, Application and Specification Table AstraZeneca Performance Enhancing Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table AstraZeneca Performance Enhancing Drugs Production Growth Rate (2014-2019) Table AstraZeneca Performance Enhancing Drugs Production Market Share (2014-2019) Figure AstraZeneca Performance Enhancing Drugs Revenue Market Share (2014-2019) Table AstraZeneca Performance Enhancing Drugs Main Business and Markets Served Table Novo Nordisk Performance Enhancing Drugs Production Sites and Area Served Table Novo Nordisk Performance Enhancing Drugs Product Introduction, Application and Specification Table Novo Nordisk Performance Enhancing Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Novo Nordisk Performance Enhancing Drugs Production Growth Rate (2014-2019) Table Novo Nordisk Performance Enhancing Drugs Production Market Share (2014-2019) Figure Novo Nordisk Performance Enhancing Drugs Revenue Market Share (2014-2019) Table Novo Nordisk Performance Enhancing Drugs Main Business and Markets Served Table BrainAlert Performance Enhancing Drugs Production Sites and Area Served Table BrainAlert Performance Enhancing Drugs Product Introduction, Application and Specification Table BrainAlert Performance Enhancing Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table BrainAlert Performance Enhancing Drugs Production Growth Rate (2014-2019) Table BrainAlert Performance Enhancing Drugs Production Market Share (2014-2019) Figure BrainAlert Performance Enhancing Drugs Revenue Market Share (2014-2019) Table BrainAlert Performance Enhancing Drugs Main Business and Markets Served Table Douglas Laboratories Performance Enhancing Drugs Production Sites and Area Served Table Douglas Laboratories Performance Enhancing Drugs Product Introduction, Application and Specification Table Douglas Laboratories Performance Enhancing Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Douglas Laboratories Performance Enhancing Drugs Production Growth Rate (2014-2019) Table Douglas Laboratories Performance Enhancing Drugs Production Market Share (2014-2019) Figure Douglas Laboratories Performance Enhancing Drugs Revenue Market Share (2014-2019) Table Douglas Laboratories Performance Enhancing Drugs Main Business and Markets Served Table Onnit Labs Performance Enhancing Drugs Production Sites and Area Served Table Onnit Labs Performance Enhancing Drugs Product Introduction, Application and Specification Table Onnit Labs Performance Enhancing Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Onnit Labs Performance Enhancing Drugs Production Growth Rate (2014-2019) Table Onnit Labs Performance Enhancing Drugs Production Market Share (2014-2019) Figure Onnit Labs Performance Enhancing Drugs Revenue Market Share (2014-2019) Table Onnit Labs Performance Enhancing Drugs Main Business and Markets Served Table Eli Lilly And Company Performance Enhancing Drugs Production Sites and Area Served Table Eli Lilly And Company Performance Enhancing Drugs Product Introduction, Application and Specification Table Eli Lilly And Company Performance Enhancing Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Eli Lilly And Company Performance Enhancing Drugs Production Growth Rate (2014-2019) Table Eli Lilly And Company Performance Enhancing Drugs Production Market Share (2014-2019) Figure Eli Lilly And Company Performance Enhancing Drugs Revenue Market Share (2014-2019) Table Eli Lilly And Company Performance Enhancing Drugs Main Business and Markets Served Figure Global Performance Enhancing Drugs Production (K Units) Growth Rate Forecast 2019-2025 Figure Global Performance Enhancing Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Performance Enhancing Drugs Sales Price (USD/Unit) Forecast 2019-2025 Figure North America Performance Enhancing Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure North America Performance Enhancing Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Performance Enhancing Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure Europe Performance Enhancing Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Performance Enhancing Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure China Performance Enhancing Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Performance Enhancing Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure Japan Performance Enhancing Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Performance Enhancing Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure Southeast Asia Performance Enhancing Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Performance Enhancing Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure India Performance Enhancing Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K Units) of Performance Enhancing Drugs by Type (2019-2025) Table Global Consumption (K Units) of Performance Enhancing Drugs by Application (2019-2025) Table Performance Enhancing Drugs Distributors List Table Performance Enhancing Drugs Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Taj Pharmaceuticals Balkan Pharmaceuticals Bayer AstraZeneca Novo Nordisk BrainAlert Douglas Laboratories Onnit Labs Eli Lilly And Company